Literature DB >> 15215172

All-trans-retinoic acid suppresses matrix metalloproteinase activity and increases collagen synthesis in diabetic human skin in organ culture.

Humaira Lateef1, Martin J Stevens, James Varani.   

Abstract

Diabetes increases susceptibility to chronic skin ulceration. The etiology of chronic wound formation in diabetic individuals is multifactoral but may be accelerated by changes in the structure and function of the skin secondary to impaired fibroblast proliferation, decreased collagen synthesis, and increased matrix metalloproteinase (MMP) expression. This study explored the effects of all-trans-retinoic acid (RA) on cellular and biochemical features of diabetic human skin in organ culture. Two-mm skin biopsies from hip or ankle were obtained from diabetic subjects and incubated for 9 days in the absence or presence of 2 micro mol/L RA. Hip skin from non-diabetic individuals served as control. Following organ culture incubation, untreated and RA-treated tissue was examined histologically after staining with hematoxylin and eosin. In parallel, organ culture-conditioned medium collected on days 5 and 7 was assayed for levels of active and total MMP-1 (interstitial collagenase) and MMP-9 (gelatinase B). The same organ culture fluids were assayed for the presence of soluble collagen. In comparison with skin from non-diabetic individuals, diabetic skin demonstrated no major differences in overall epidermal thickness or collagen production (both were increased in RA-treated tissue as compared to non-RA-treated tissue). In contrast, levels of MMP-9 (active forms) were elevated in organ culture fluid from diabetic skin as compared to non-diabetic control skin. In the presence of RA, active forms of both MMP-1 and MMP-9 were reduced. Together, these data suggest that RA has the capacity to improve structure and function of diabetic skin, and that a major effect is on reduction of collagen-degrading MMPs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215172      PMCID: PMC1618544          DOI: 10.1016/S0002-9440(10)63285-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro.

Authors:  J Varani; D Spearman; P Perone; S E Fligiel; S C Datta; Z Q Wang; Y Shao; S Kang; G J Fisher; J J Voorhees
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Pretreatment with topical all-trans-retinoic acid is beneficial for wound healing in genetically diabetic mice.

Authors:  Y Kitano; K Yoshimura; G Uchida; K Sato; K Harii
Journal:  Arch Dermatol Res       Date:  2001-11       Impact factor: 3.017

3.  Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation.

Authors:  M A Loots; E N Lamme; J R Mekkes; J D Bos; E Middelkoop
Journal:  Arch Dermatol Res       Date:  1999 Feb-Mar       Impact factor: 3.017

4.  Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization.

Authors:  Nor Eddine Sounni; Eugenia N Baramova; Carine Munaut; Erik Maquoi; Francis Frankenne; Jean-Michel Foidart; Agnès Noël
Journal:  Int J Cancer       Date:  2002-03-01       Impact factor: 7.396

5.  Mechanisms of induction of human tissue inhibitor of metalloproteinases-1 (TIMP-1) gene expression by all-trans retinoic acid in combination with basic fibroblast growth factor.

Authors:  H F Bigg; R McLeod; J G Waters; T E Cawston; I M Clark
Journal:  Eur J Biochem       Date:  2000-07

6.  Inhibition of type I procollagen production in photodamage: correlation between presence of high molecular weight collagen fragments and reduced procollagen synthesis.

Authors:  James Varani; Patricia Perone; Suzanne E G Fligiel; Gary J Fisher; John J Voorhees
Journal:  J Invest Dermatol       Date:  2002-07       Impact factor: 8.551

7.  Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway.

Authors:  Sang-Oh Yoon; Soo-Jin Park; Sun Young Yoon; Chang-Hyun Yun; An-Sik Chung
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

8.  Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing.

Authors:  David J Margolis; Lynne Allen-Taylor; Ole Hoffstad; Jesse A Berlin
Journal:  Diabetes Care       Date:  2002-10       Impact factor: 19.112

9.  Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin.

Authors:  J Varani; Y Hattori; Y Chi; T Schmidt; P Perone; M E Zeigler; D J Fader; T M Johnson
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

10.  Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.

Authors:  G E Davis; K A Pintar Allen; R Salazar; S A Maxwell
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  24 in total

1.  Regulation of collagen turnover in human skin fibroblasts exposed to a gadolinium-based contrast agent.

Authors:  Narasimharao Bhagavathula; Marissa DaSilva; Muhammad N Aslam; Michael K Dame; Roscoe L Warner; Yiru Xu; Gary J Fisher; Kent J Johnson; Richard Swartz; James Varani
Journal:  Invest Radiol       Date:  2009-08       Impact factor: 6.016

Review 2.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 3.  The role of adult tissue-derived stem cells in chronic leg ulcers: a systematic review focused on tissue regeneration medicine.

Authors:  Bruno Amato; Rita Compagna; Maurizio Amato; Lucia Butrico; Francesco Fugetto; Mariia D Chibireva; Andrea Barbetta; Marco Cannistrà; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2015-09-24       Impact factor: 3.315

Review 4.  Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition.

Authors:  Britta Kunkemoeller; Themis R Kyriakides
Journal:  Antioxid Redox Signal       Date:  2017-08-10       Impact factor: 8.401

5.  MDI 301, a non-irritating retinoid, induces changes in human skin that underlie repair.

Authors:  James Varani; Kevin Fay; Patricia Perone
Journal:  Arch Dermatol Res       Date:  2006-12-05       Impact factor: 3.017

6.  Collagenolytic activity is suppressed in organ-cultured human skin exposed to a gadolinium-based MRI contrast agent.

Authors:  Patricia A Perone; Stephanie L Weber; Marissa DaSilva; Tejaswi Paruchuri; Narasimharao Bhagavathula; Muhammad N Aslam; Michael K Dame; Kent J Johnson; Richard D Swartz; James Varani
Journal:  Invest Radiol       Date:  2010-01       Impact factor: 6.016

7.  Human skin organ culture for assessment of chemically induced skin damage.

Authors:  James Varani
Journal:  Expert Rev Dermatol       Date:  2012-06-01

8.  The Göttingen minipig for assessment of retinoid efficacy in the skin: comparison of results from topically treated animals with results from organ-cultured skin.

Authors:  Michael K Dame; Tejaswi Paruchuri; Marissa DaSilva; Narasimharao Bhagavathula; William Ridder; James Varani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-18       Impact factor: 2.416

9.  MDI 301, a nonirritating retinoid, improves abrasion wound healing in damaged/atrophic skin.

Authors:  Roscoe L Warner; Narasimharao Bhagavathula; Kamalakar Nerusu; Andrew Hanosh; Shannon D McClintock; Madhav K Naik; Kent J Johnson; Isaac Ginsburg; James Varani
Journal:  Wound Repair Regen       Date:  2008 Jan-Feb       Impact factor: 3.617

10.  Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected].

Authors:  R E B Watson; S Ogden; L F Cotterell; J J Bowden; J Y Bastrilles; S P Long; C E M Griffiths
Journal:  Br J Dermatol       Date:  2009-04-28       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.